Petition updateAllow AHSCT treatment for patients with Multiple Sclerosis in America

Debate: Non-myeloablative HSCT should be offered as a firstline DMT - MS Cutting Edge Science

Timothy PFremont, MI, United States
Mar 6, 2023

https://neurologyacademy.org/articles/debate-non-myeloablative-hsct-should-be-offered-as-a-firstline-dmt-ms-cutting-edge-science

Copy link
WhatsApp
Facebook
Nextdoor
Email
X